HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$328.14
Day range
$300.00 - $314.59
Year range
$168.25 - $368.29
Market cap
6.74B USD
Avg Volume
406.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 62.18M | — |
Operating expense | 176.33M | 78.95% |
Net income | -106.96M | -8.33% |
Net profit margin | -172.04 | — |
Earnings per share | -4.92 | 7.87% |
EBITDA | -116.01M | -17.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 998.63M | 329.79% |
Total assets | 1.07B | 351.02% |
Total liabilities | 296.11M | 37.27% |
Total equity | 777.16M | — |
Shares outstanding | 21.81M | — |
Price to book | 9.21 | — |
Return on assets | -26.76% | — |
Return on capital | -31.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -106.96M | -8.33% |
Cash from operations | -66.98M | 21.12% |
Cash from investing | -202.39M | -503.18% |
Cash from financing | 7.46M | -61.89% |
Net change in cash | -261.91M | -1,629.83% |
Free cash flow | -35.83M | 29.36% |
About
Founded
2011
Headquarters
Website
Employees
376
